Silverman Joshua (CIK 1524858) reported 15 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy PTPI (4.4M shares), Buy QCLS (162,162 shares), Buy PMCB (30,000 shares), Buy PMCB (30,000 shares), Buy PMCB (40,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Petros Pharmaceuticals, Inc. (PTPI) | Director | Buy | 4.4M | $0 |
| 2026-04-15 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | Buy | 162,162 | $0 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | Buy | 30,000 | $23,400 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | Buy | 30,000 | $23,700 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | Buy | 40,000 | $33,200 |
| 2026-01-02 | Petros Pharmaceuticals, Inc. (PTPI) | Director | Buy | 4.4M | $0 |
| 2025-12-12 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | Buy | 575,000 | $0 |
| 2025-12-12 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | Sell | 258,750 | $263,925 |
| 2025-11-14 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | Buy | 91,356 | $0 |
| 2025-10-17 | TAO Synergies Inc. (TAOX) | Executive Chairman | Buy | 100,000 | $0 |
| 2025-10-17 | TAO Synergies Inc. (TAOX) | Executive Chairman | Sell | 40,000 | $289,200 |
| 2025-10-06 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | Buy | 8,644 | $0 |
| 2025-07-02 | TAO Synergies Inc. (TAOX) | Executive Chairman | Buy | 41,919 | $0 |
| 2025-07-02 | TAO Synergies Inc. (TAOX) | Executive Chairman | Sell | 16,768 | $131,629 |
| 2025-02-21 | Petros Pharmaceuticals, Inc. (PTPI) | Director | Buy | 1.0M | $0 |
Source: SEC Form 4 filings · as of 2026-06-05